Congress Puts Focus Back On Drug Pricing With AbbVie Subpoena

 
• By Brenda Sandburg

House Oversight Committee Chair says AbbVie has failed to comply with requests for documents in committee's investigation of the drug pricing of 12 pharma companies.

Congress and law as congressional subpoena and political legislation concept or government investigation and legislative reform in the United States with 3D illustration elements.
House ovesight committee plans to subpoena AbbVie for Humira and Imbruvica pricing information • Source: Shutterstock

More from Pricing Debate

More from Market Access